Cerebral blood-flow simulations
Lithuanian SME Vittamed developed the world’s first non-invasive ICP absolute value measurement device, but faces challenges in accuracy, user-friendliness, and cost effectiveness. Simula Research Laboratory aims to improve technology by using HPC for ICP simulation.
Start date: 01/07/2013
Duration in months: 18
Problem Description
The objective of the project is the development of blood flow simulation model for the non-invasive measurement of intracranical pressure (ICP), demonstrating the feasibility and the advantages of these simulations performed on HPC systems.
Goals
New services
Challenges
The experiment involved creating mathematical models and software tools for simulations of cerebral blood flow in the ophthalmic artery, adapted for HPC systems. The goal was to demonstrate the feasibility and benefits of these simulations to Vittamed.
Innovation results
A Carotid/Opthalmic Artery model, based on MRI imaging, has been developed to simulate blood flow on a multi-processor HPC system. Vittamed plans to use this model in its non-invasive ICP measurement technology, allowing non-experts to perform simulations with specified parameters.
Business impact
Vittamed can reduce time to market and design more accurate products using cloud-based HPC simulations, targeting glaucoma diagnostics. This could lead to innovative technologies and treatment methods, creating a commercial opportunity for SME in the global market.